Literature DB >> 23571238

Conjunctival erosion after glaucoma drainage device surgery: a feasible option.

Suneeta Dubey1, Baswati Prasanth, Manisha C Acharya, Ritesh Narula.   

Abstract

Glaucoma drainage devices (GDDs) have been used in the management of complicated glaucomas. GDDs are associated with various complications such as tube migration, tube or plate exposure or extrusion, ocular motility disturbance and infection. Erosion of conjunctiva and exposure of the GDD remains a risk factor for the development of endophthalmitis. A wide range of materials have been used for this purpose, including sclera, dura, pericardium, fascia lata and cornea. However, there is no evidence to prove that any of these methods is superior to another for providing tectonic durability in the long term. In this report, we present a case of neovascular glaucoma, who developed conjunctival melting over the tube of an Ahmed Glaucoma Valve implant and was successfully managed with Cap Doxycycline.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571238      PMCID: PMC3759109          DOI: 10.4103/0301-4738.99852

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Glaucoma drainage devices (GDDs) have been used in the management of complicated glaucomas, with a success rates of 22–97% in neovascular glaucoma (NVG).[12] Amongst the various complications associated with GDD,[3] erosion of conjunctiva and exposure of the GDD remains a risk factor for endophthalmitis. In a series of 542 eyes, conjunctival erosion overlying the Ahmed Glaucoma valve AGV was present in six of the nine eyes that developed endophthalmitis,[4] thereby emphasizing on providing a durable coverage for exposed GDD. Hence, it is critical to choose an ideal material for the coverage of exposed GDD amongst the wide range of materials available,[567] with no evidence to prove the superiority of any for providing tectonic durability in the long term.[8] In this, we present a case of NVG who developed conjunctival melting over the tube of an Ahmed Valve implant and was successfully managed with Cap Doxycycline.

Case Report

A 69-year-old male, known case of chronic angle closure glaucoma with advanced glaucomatous neuropathy, was on medical management for his raised intraocular pressures. He was highly noncompliant with his medications and subsequently went on to develop vascular occlusions (superotemporal branched retinal vascular occlusion in the right eye and central retinal vascular occlusion in the left eye) due to sustained high intraocular pressures in both his eyes in a sequential manner followed by NVG in the left eye. The patient had undergone phacotrabeculectomy with Mitomycin C MMC in both the eyes for chronic angle closure glaucoma 6 months back. There was a diffuse functional bleb with an intraocular pressure of 12 mmHg in right eye. The bleb was flat and vascularized in the left eye and intraocular pressure in the left eye was 36 mmHg. Ahmed Glaucoma Valve with donor scleral patch graft was implanted along with intravitreal Inj Avastin for NVG in the left eye. One month postoperative follow-up of the patient revealed a well-functioning implant with an exposed scleral graft and overlying conjunctival melt [Fig. 1]. The patient was put on Cap Doxycycline (100 mg bd) orally, eye drop Prednisolone acetate 8 times/day, E/D Tear substitute 8 times/day and continued eye drop Moxifloxacin 4 times/day, with a review on alternate days. After 2 weeks, there was complete epithelial healing over the exposed scleral graft [Fig. 2], anterior chamber was deep and the tube was functioning well. Doxycycline was continued once daily orally further for a period of 4 weeks and then stopped. During the 4 months follow-up period, the tube remained covered by intact conjunctival epithelium. On the last follow-up visit, the patient had a visual acuity of 6/18 in the left eye, the tube remained covered by intact conjunctival epithelium, and intraocular pressure was 13 mmHg on eye drop Brimonidine and the patient was advised a 3-monthly review [Fig. 3].
Figure 1

Avascularized and exposed scleral patch with functional implant

Figure 2

Showing total epithelialization over the exposed sclera

Figure 3

Last follow-up showing a completely covered tube with deep anterior chamber

Avascularized and exposed scleral patch with functional implant Showing total epithelialization over the exposed sclera Last follow-up showing a completely covered tube with deep anterior chamber

Discussion

With the advent of donor autologous tissue for covering glaucoma drainage tubes, the incidence of tube erosion has decreased from 30% to less than 5%. In these handful of patients, mere observation is not advisable as the tube may serve as a nidus for infection, necessitating the removal of the tube. The causes of conjunctival erosion, though not well defined, probably comprise poor tissue turgor and mechanical rubbing of the eyelid margin against the tissue patch graft, excessive conjunctival tension over the tube, tube malposition, lack of a smooth tapered surface between the patch graft and host with poor ocular lubrication and minute amounts of absolute alcohol retained in the donor sclera.[9] Doxycycline is a broad-spectrum antibiotic that chelates metal ions and is frequently used as part of the treatment of ocular surface diseases. Its therapeutic value has been attributed to an ability to inhibit matrix metalloproteinase (MMP) activity and both MMP and interleukin (IL)-1 synthesis. In a recent published report, rapid resolution and further recurrence of corneal erosions were prevented with a combination of Doxycycline and steroids.[10] We presume in our case the therapeutic effects of Doxycycline and corticosteroids may be primarily the result of inhibition of metalloproteinase-9, or they may be secondary to their anti-inflammatory activity. The rapid clinical response to Doxycycline and corticosteroids in our patient could probably be the result of direct inhibition of inflammation or inflammation-induced metalloproteinase activity, along with an improved ocular surface with the use of frequent lubrication thereby reducing the mechanical rubbing force. There is paucity of literature with regards to the best method to resolve the challenging problem of conjunctival erosion following GDD. Repeated surgical attempts at repair may be required and surgeons may find it intuitive to perform direct closure of dehisced conjunctiva. However, scarring at the implant site and poor conjunctival status due to chronic use of medications greatly reduces the chances of success. Conjunctival, scleral and amniotic membrane grafts have been reportedly used in the repair of exposed GDD. Our patient was managed conservatively with an impressive postoperative outcome. This adds to our knowledge on the pre-existing practices on the management of NVGs and may serve as a feasible alternative option to the current management practices. Thus, simple conservative measures can be attempted before resorting to complex surgeries.
  10 in total

Review 1.  Avoiding and managing complications of glaucoma drainage implants.

Authors:  Quang H Nguyen
Journal:  Curr Opin Ophthalmol       Date:  2004-04       Impact factor: 3.761

2.  Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids.

Authors:  D Dursun; M C Kim; A Solomon; S C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2001-07       Impact factor: 5.258

3.  Scleral patch grafts with Molteno setons.

Authors:  J Freedman
Journal:  Ophthalmic Surg       Date:  1987-07

4.  New implant for drainage in glaucoma. Clinical trial.

Authors:  A C Molteno
Journal:  Br J Ophthalmol       Date:  1969-09       Impact factor: 4.638

5.  Residual ethanol content of donor sclera after storage in 95% ethanol and saline rinse of various durations.

Authors:  R W Enzenauer; E A Sieck; D E Vavra; E P Jacobs
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

Review 6.  Glaucoma drainage devices: pros and cons.

Authors:  M H Assaad; G Baerveldt; E J Rockwood
Journal:  Curr Opin Ophthalmol       Date:  1999-04       Impact factor: 3.761

Review 7.  Endophthalmitis associated with the Ahmed glaucoma valve implant.

Authors:  A A Al-Torbak; S Al-Shahwan; I Al-Jadaan; A Al-Hommadi; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

8.  Pericardial patch grafts in glaucoma implant surgery.

Authors:  T Raviv; D S Greenfield; J M Liebmann; P A Sidoti; H Ishikawa; R Ritch
Journal:  J Glaucoma       Date:  1998-02       Impact factor: 2.503

9.  Patch grafts of dehydrated cadaveric dura mater for tube-shunt glaucoma surgery.

Authors:  J D Brandt
Journal:  Arch Ophthalmol       Date:  1993-10

10.  Comparison of single thickness and double thickness processed pericardium patch graft in glaucoma drainage device surgery: a single surgeon comparison of outcome.

Authors:  Dara Lankaranian; Ricardo Reis; Jeffrey D Henderer; Sung Choe; Marlene R Moster
Journal:  J Glaucoma       Date:  2008 Jan-Feb       Impact factor: 2.503

  10 in total
  5 in total

1.  Role of oral doxycycline and large diameter bandage contact lens in the management of early post-trabeculectomy bleb leak.

Authors:  Turaga Kiranmaye; Chandrasekhar S Garudadri; Sirisha Senthil
Journal:  BMJ Case Rep       Date:  2014-12-05

2.  Management of implant plate exposure of silicone Ahmed glaucoma valve: a review of six cases.

Authors:  Avik Kumar Roy; Sirisha Senthil
Journal:  GMS Ophthalmol Cases       Date:  2016-09-02

3.  Safety and efficacy of Ahmed glaucoma valve implantation in refractory glaucomas in Northern Indian eyes.

Authors:  Suneeta Dubey; Vijeta Sharma; Anugya Agrawal; Lokesh Chauhan; Gordon Douglas
Journal:  Saudi J Ophthalmol       Date:  2014-06-25

4.  Wound Dehiscence and Device Migration after Subconjunctival Bevacizumab Injection with Ahmed Glaucoma Valve Implantation.

Authors:  Arezoo Miraftabi; Naveed Nilforushan
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar

5.  Novel Use of Double-Layer Amniotic Membrane Technique in Tube Erosion in a Pediatric Patient.

Authors:  Altan Atakana Ozcan; Burak Ulas
Journal:  Beyoglu Eye J       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.